Artia Global Partners’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,756
Closed -$27K 54
2025
Q4
$27K Buy
+8,756
New +$43.6K ﹤0.01% 55

Other funds holding LYRA

Artia Global Partners's LYRA Position: Q1 2026 in Review

Artia Global Partners sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 8,756 shares — an estimated $27K sold.

Artia Global Partners first reported a position in LYRA in Q4 2025 and held it in 1 quarter. The position peaked at $27K in Q4 2025. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

  • Artia Global Partners reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Artia Global Partners sold 8,756 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $27K.
  • Artia Global Partners first reported a position in LYRA THERAPEUTICS INC in Q4 2025 and held it in 1 quarter.
  • Artia Global Partners's LYRA THERAPEUTICS INC position peaked at $27K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.